DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of two abstracts for poster presentations on December 6, 2009 at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, LA.
